How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
06 12 2021
Historique:
received: 15 06 2020
pubmed: 20 8 2020
medline: 15 3 2022
entrez: 20 8 2020
Statut: ppublish

Résumé

Prosthetic joints are at risk of becoming infected during an episode of bacteremia, especially during Staphylocococcus aureus bacteremia. However, it is unclear how often asymptomatic periprosthetic joint infection (PJI) occurs, and whether additional diagnostics should be considered. In this multicenter study, we retrospectively analyzed a cohort of patients with a late acute (hematogenous) PJI between 2005-2015 who had concomitant prosthetic joints in situ. Patients without at least 1 year of follow-up were excluded. We included 91 patients with a hematogenous PJI and 108 concomitant prosthetic joints. The incident PJI was most frequently caused by Staphylococcus aureus (43%), followed by streptococci (26%) and Gram-negative rods (18%). Of 108 concomitant prosthetic joints, 13 were symptomatic, of which 10 were subsequently diagnosed as a second PJI. Of the 95 asymptomatic prosthetic joints, 1 PJI developed during the follow-up period and was classified as a "missed" PJI at the time of bacteremia with S. aureus (1.1%). Infected prosthetic joints were younger than the noninfected ones in 67% of cases, and prosthetic knees were affected more often than prosthetic hips (78%). During an episode of hematogenous PJI, concomitant asymptomatic prosthetic joints have a very low risk of being infected, and additional diagnostic work-up for these joints is not necessary.

Sections du résumé

BACKGROUND
Prosthetic joints are at risk of becoming infected during an episode of bacteremia, especially during Staphylocococcus aureus bacteremia. However, it is unclear how often asymptomatic periprosthetic joint infection (PJI) occurs, and whether additional diagnostics should be considered.
METHODS
In this multicenter study, we retrospectively analyzed a cohort of patients with a late acute (hematogenous) PJI between 2005-2015 who had concomitant prosthetic joints in situ. Patients without at least 1 year of follow-up were excluded.
RESULTS
We included 91 patients with a hematogenous PJI and 108 concomitant prosthetic joints. The incident PJI was most frequently caused by Staphylococcus aureus (43%), followed by streptococci (26%) and Gram-negative rods (18%). Of 108 concomitant prosthetic joints, 13 were symptomatic, of which 10 were subsequently diagnosed as a second PJI. Of the 95 asymptomatic prosthetic joints, 1 PJI developed during the follow-up period and was classified as a "missed" PJI at the time of bacteremia with S. aureus (1.1%). Infected prosthetic joints were younger than the noninfected ones in 67% of cases, and prosthetic knees were affected more often than prosthetic hips (78%).
CONCLUSIONS
During an episode of hematogenous PJI, concomitant asymptomatic prosthetic joints have a very low risk of being infected, and additional diagnostic work-up for these joints is not necessary.

Identifiants

pubmed: 32813012
pii: 5894433
doi: 10.1093/cid/ciaa1222
pmc: PMC9187975
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3820-e3824

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Clin Orthop Relat Res. 2010 Jan;468(1):45-51
pubmed: 19554385
J Arthroplasty. 2014 Jul;29(7):1331
pubmed: 24768547
Scand J Infect Dis. 2008;40(11-12):973-7
pubmed: 18615359
J Infect. 2018 Apr;76(4):328-334
pubmed: 29395369
J Arthroplasty. 2016 Dec;31(12):2862-2866
pubmed: 27444849
Open Forum Infect Dis. 2019 Dec 05;6(12):ofz515
pubmed: 31890721
J Infect. 2011 Jul;63(1):17-22
pubmed: 21663971
Clin Infect Dis. 2001 Feb 15;32(4):647-9
pubmed: 11181131
Open Forum Infect Dis. 2020 May 14;7(5):ofaa068
pubmed: 32432148
J Arthroplasty. 2016 Nov;31(11):2564-2568
pubmed: 27567058
Am J Med. 2006 Nov;119(11):993.e7-10
pubmed: 17071171
J Bone Joint Surg Am. 2009 Jan;91(1):128-33
pubmed: 19122087
Open Forum Infect Dis. 2019 May 07;6(6):ofz218
pubmed: 31214625
Lancet. 2004 Aug 21-27;364(9435):703-5
pubmed: 15325835
Acta Orthop. 2015 Jun;86(3):321-5
pubmed: 25813645
J Infect. 2019 Jan;78(1):40-47
pubmed: 30092305
Am J Med. 2016 Feb;129(2):221.e11-20
pubmed: 26453989
J Arthroplasty. 2014 Nov;29(11):2181-6
pubmed: 25124809
N Engl J Med. 2001 Jan 4;344(1):11-6
pubmed: 11136954
J Bone Joint Surg Am. 2020 Jul 1;102(13):1160-1168
pubmed: 32618923

Auteurs

Marjan Wouthuyzen-Bakker (M)

Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, the Netherlands.

Marine Sebillotte (M)

Department of Infectious Diseases and Intensive Care Medicine, Rennes University Hospital, Rennes, France.

Cédric Arvieux (C)

Department of Infectious Diseases and Intensive Care Medicine, Rennes University Hospital, Rennes, France.
Great West Reference centers for Complex Bone and Joint Infections (CRIOGO), Rennes, France.

Marta Fernandez-Sampedro (M)

Service of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, University of Cantabria, Instituto de investigación sanitaria Valdecilla (IDIVAL), Santander, Spain.

Eric Senneville (E)

Department of Infectious Diseases, Lille, University Hospital Gustave Dron Hospital, Tourcoing, France.

José Maria Barbero (JM)

Department of Internal Medicine. Hospital Universitario Principe de Asturias, Madrid, Spain.

Jaime Lora-Tamayo (J)

Department of Internal Medicine. Hospital Universitario 12 de Octubre. Instituto de Investigación i+12. Madrid, Spain.

Craig Aboltins (C)

The Department of Infectious Diseases, Northern Health, Melbourne, Australia.
The University of Melbourne, Northern Clinical School, Melbourne, Australia.

Rihard Trebse (R)

Service for Bone Infections, Valdoltra Orthopaedic Hospital, the Faculty of Medicine, University of Ljublijana, Ankaran, Slovenia.

Mauro José Salles (MJ)

Santa Casa de São Paulo School of Medical Sciences and Musculoskeletal infection group, Federal University of São Paulo, Brasil.

Tobias Siegfried Kramer (TS)

Institute for hygiene and environmental medicine Charité-Universitätsmedizin Berlin, Germany.
Evangelisches Waldkrankenhaus Spandau, BerlinGermany.

Matteo Ferrari (M)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.

Joaquín Garcia-Cañete (J)

Department of Internal Medicine-Emergency, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz, Universidad Autónoma de Madrid (UAM), Madrid, Spain.

Natividad Benito (N)

Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Barcelona, Spain.
Department of Medicine. Universitat Autònoma de Barcelona, Spain.

Vicens Diaz-Brito (V)

Infectious Diseases Unit, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain.

Maria Dolores Del Toro (MD)

Unidad Clínica de Enfermedades Infecciosa y Microbiología. Universidad de Sevilla. Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.

Matthew Scarborough (M)

Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, England.

Alex Soriano (A)

Service of Infectious Diseases, Hospital Clínic, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH